Highly experienced CDMO expert Michel Spagnol appointed Chairman of Astraveus
Paris, France, 28 November, 2023 – Astraveus SAS (“Astraveus” or the “Company”), the creator of modular, microfluidic cell foundries that transform cell and gene therapy (CGT) manufacturing, today announces the appointment of Michel Spagnol as its new Chairman of the Board. Michel joins existing Board members Jérémie Laurent, CEO; Alain Huriez, Director; AdBio Partners; Christian Ulrich, Director, M Ventures; Fiona MacLaughlin, Director, JJDC; and Laurent Higueret, Director, BPI France Large Venture.
